Aurinia Pharmaceuticals Inc. — SC 13D Filings
5 SC 13D filings on record
This page lists all SC 13D filings submitted to the SEC by Aurinia Pharmaceuticals Inc. (AUPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aurinia Pharmaceuticals Inc. has filed 5 SC 13D documents with the SEC since 2014. To view all SEC filings by Aurinia Pharmaceuticals Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
4/A
40-F
40-F/A
40FR12B
40FR12B/A
6-K
6-K/A
8-K
8-K/A
ARS
CERTNAS
D
DEF 14A
DEFA14A
EFFECT
F-10
F-10/A
F-X
FWP
PRE 14A
PX14A6G
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SUPPL
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D | — | 0001214659-24-016381 | Sep 12, 2024 | — |
| SC 13D | SC 13D | 0001104659-19-020260 | Apr 8, 2019 | — |
| SC 13D | THE SCHEDULE 13D | 0000921895-17-001237 | May 1, 2017 | — |
| SC 13D | GROWTH EQUITY OPPORTUNITIES FUND III, LLC / AURINIA PHARMACEUTICALS INC. | 0001072613-17-000009 | Jan 9, 2017 | — |
| SC 13D | SCHEDULE 13D | 0001144204-16-111528 | Jul 5, 2016 | — |